Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction

European Journal of Internal Medicine

Volumn 20, Issue 5, 2009, Pages 527-532

  Aminian, Adel ^a,b   Boudjeltia, Karim Zouaoui ^a,b   Babar, Sajida ^a,b   Van Antwerpen, Pierre ^a,b   Lefebvre, Pascal ^a,b   Crasset, Vincent ^a,b   Leone, Attilio ^a,b   Ducobu, Jean ^a,b   Friart, Alain ^a,b   Vanhaeverbeek, Michel ^a,b  

^a Tivoli University Hospital   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Myeloperoxidase; Myocardial infarction; Stable angina; Stenting

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LACTOFERRIN; LOW MOLECULAR WEIGHT HEPARIN; MYELOPEROXIDASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL COUNT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEROLOGY; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LACTOFERRIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHIL ACTIVATION; PEROXIDASE; STENTS; TIME FACTORS;

EID: 69249208576     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.05.008     Document Type: Article

References (37)

1. De Servi S., Mazzone A., Ricevuti G., Fioravanti A., Bramucci E., Angoli L., et al. Granulocyte activation after coronary angioplasty in humans. Circulation 82 1 (Jul 1990) 140-146
2. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R.L., Hajjar D.P., et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte generated reactive nitrogen species. J Clin Invest 105 (2000) 1095-1108
3. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276 (2001) 41279-41287
4. Abu-Soud H.M., and Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 275 (2000) 37524-37532
5. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., et al. Myeloperoxidase, a leukocyte derived vascular NO oxidase. Science 296 (2002) 2391-2394
6. Vita J.A., Brennan M.L., Gokce N., Mann S.A., Goormastic M., Shishehbor M.H., et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110 (2004) 1134-1139
7. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
8. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 12 (2003) 1440-1445
9. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
10. Gach O., Biemar C., Nys M., Deby-Dupont G., Chapelle J.P., Deby C., et al. Early release of neutrophil markers of activation after direct stenting in patients with unstable angina. Coron Artery Dis 16 1 (Feb 2005) 59-65
11. Gach O., Nys M., Deby-Dupont G., Chapelle J.P., Lamy M., Pierard L.A., et al. Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients. Int J Cardiol 112 1 (Sep 10 2006) 59-65
12. Rudolph V., Steven D., Gehling U.M., Goldmann B., Rudolph T.K., Friedrichs K., et al. Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease. Free Radic Biol Med 42 4 (Feb 15 2007) 460-465
13. Van der Wal A.C., Becker A.E., Van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36
14. Liuzzo G., Goronzy J.J., Yang H., Kopecky S.L., Holmes D.R., Frye R.L., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101 (2000) 2883-2888
15. Weyand C.M., Goronzy J.J., Liuzzo G., Kopecky S.L., Holmes Jr. D.R., and Frye R.L. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 76 (2001) 1011-1020
16. Moreno P.R., Falk E., Palacios I.F., Newell J.B., Fuster V., Fallon J.T., et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90 (1994) 775-778
17. Zalai C.V., Kolodziejczyk M.D., Pilarski L., Christov A., Nation P.N., Lundstrom-Hobman M., et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 38 (2001) 1340-1347
18. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
19. Mazzone A., De Servi S., Ricevuti G., Mazzucchelli I., Fossati G., Pasotti D., et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88 (1993) 358-363
20. de Servi S., Mazzone A., Ricevuti G., Mazzucchelli I., Fossati G., Angoli L., et al. Expression of neutrophil and monocyte CD11B/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. Am J Cardiol 78 (1996) 564-568
21. Biasucci L.M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 27 (1996) 611-616
22. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
23. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
24. Biasucci L.M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94 (1996) 874-877
25. Liuzzo G., Biasucci L.M., Gallimore J.R., Caligiuri G., Buffon A., Rebuzzi A.G., et al. Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 34 (1999) 1696-1703
26. Srivastava C.H., Rado T.A., Bauerle D., and Broxmeyer H.E. Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-alpha. The Journal of Immunology 146 Issue 3 (1991) 1014-1019
27. Hu Z.B., Ma W., Uphoff C.C., Metge K., Gignac S.M., and Drexler H.G. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood 82 5 (Sep 1 1993) 1599-1607
28. Inoue T., Sakai Y., Morooka S., Hayashi T., Takayanagi K., and Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 28 (1996) 1127-1133
29. Mickelson J.K., Lakkis N.M., Villarreal-Levy G., Hughes B.J., and Smith C.W. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?. J Am Coll Cardiol 28 (1996) 345-353
30. Neumann F.J., Ott I., Gawaz M., Puchner G., and Schomig A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 27 (1996) 819-824
31. Baldus S., Rudolph V., Roiss M., Ito W.D., Rudolph T.K., Eiserich J.P., Sydow K., et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113 15 (Apr 18 2006) 1871-1878
32. Li G., Keenan A.C., Young J.C., Hall M.J., Pamuklar Z., Ohman E.M., et al. Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirudin on myeloperoxidase release from neutrophils. Arterioscler Thromb Vasc Biol. 27 (2007) 1850-1856
33. Potempa L.A., Zeller J.M., Fiedel B.A., Kinoshita C.M., and Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 12 4 (Aug 1988) 391-405
34. Gaspardone A., and Versaci F. Coronary stenting and inflammation. Am J Cardiol 96 12A (Dec 19 2005) 65L-70L
35. Mehta J., Dinerman J., Mehta P., Saldeen T.G., Lawson D., Donnelly W.H., et al. Neutrophil function in ischemic heart disease. Circulation 79 (1989) 549-556
36. Rudolph T.K., Rudolph V., Witte A., Klinke A., Szoecs K., Lau D., et al. Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function. Int J Cardiol (2008) [Electronic publication ahead of print]
37. Yang J., Cheng Y., Ji R., and Zhang C. Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia. Am J Physiol Heart Circ Physiol 291 (2006) H.